HomeBiotech

Biotech

REGENXBIO to Participate in Stifel 2026 Healthcare Conference

REGENXBIO to Participate in Stifel 2026 Healthcare Conference

November 4, 2026

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics to Present at November Investor Conferences

November 4, 2026

Nanalysis Settles Interest Payment on Promissory Notes and Provides Corporate Update

Nanalysis Settles Interest Payment on Promissory Notes and Provides Corporate Update

November 4, 2026

Rocket One’s Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients

Rocket One’s Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients

November 4, 2026

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS

November 3, 2026

Viking Therapeutics to Participate at Upcoming Investor Conferences

Viking Therapeutics to Participate at Upcoming Investor Conferences

November 3, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 3, 2026

Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences

Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences

November 3, 2026

BIO-TECHNE DECLARES DIVIDEND

BIO-TECHNE DECLARES DIVIDEND

November 3, 2026

ADC Therapeutics Announces New Employee Inducement Grant

ADC Therapeutics Announces New Employee Inducement Grant

November 3, 2026

1 2 3 … 163 »